Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Taniguchi

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Biofabrication|October 22, 2025
Bio-3D printing with smooth muscle cells derived from human iPSCs via neural crest and its application for the tracheal regenerationShintaro Hashimoto, Daisuke Taniguchi, Ryoichiro Doi, et al.
Frontiers in Aging Neuroscience|February 16, 2026
Spontaneous tauopathy with parkinsonism in an aged cynomolgus macaqueMirai Takahashi, Daisuke Taniguchi, Manabu Funayama, et al.
Plos One|March 9, 2019
Regeneration of esophagus using a scaffold-free biomimetic structure created with bio-three-dimensional printingYosuke Takeoka, Keitaro Matsumoto, Daisuke Taniguchi, et al.
Plos One|April 24, 2019
Correction: Regeneration of esophagus using a scaffold-free biomimetic structure created with bio-three-dimensional printingYosuke Takeoka, Keitaro Matsumoto, Daisuke Taniguchi, et al.
Neurobiology of Disease|June 20, 2024
Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's diseaseToshiki Tezuka, Mayu Ishiguro, Daisuke Taniguchi, et al.
The EMBO Journal|October 14, 2025
Ubiquilin-2 liquid droplets catalyze α-synuclein fibril formationTomoki Takei, Yukiko Sasazawa, Daisuke Noshiro, et al.
BMJ Open|February 12, 2022
Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson's disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD)Taku Hatano, Genko Oyama, Yasushi Shimo, et al.
Nature Medicine|May 29, 2023
Propagative α-synuclein seeds as serum biomarkers for synucleinopathiesAyami Okuzumi, Taku Hatano, Gen Matsumoto, et al.
BMJ Open|October 21, 2025
Randomised, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of antibiotic faecal microbiota transplantation in patients with Parkinson's disease (FLORA-PD): a study protocolHaruka Takeshige-Amano, Eriko Igami, Ayami Okuzumi, et al.
Scientific Reports|March 15, 2023
Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson's disease in JapanGenko Oyama, Maximilien Burq, Taku Hatano, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Biofabrication|October 22, 2025
Bio-3D printing with smooth muscle cells derived from human iPSCs via neural crest and its application for the tracheal regenerationShintaro Hashimoto, Daisuke Taniguchi, Ryoichiro Doi, et al.
Frontiers in Aging Neuroscience|February 16, 2026
Spontaneous tauopathy with parkinsonism in an aged cynomolgus macaqueMirai Takahashi, Daisuke Taniguchi, Manabu Funayama, et al.
Plos One|March 9, 2019
Regeneration of esophagus using a scaffold-free biomimetic structure created with bio-three-dimensional printingYosuke Takeoka, Keitaro Matsumoto, Daisuke Taniguchi, et al.
Plos One|April 24, 2019
Correction: Regeneration of esophagus using a scaffold-free biomimetic structure created with bio-three-dimensional printingYosuke Takeoka, Keitaro Matsumoto, Daisuke Taniguchi, et al.
Neurobiology of Disease|June 20, 2024
Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's diseaseToshiki Tezuka, Mayu Ishiguro, Daisuke Taniguchi, et al.
The EMBO Journal|October 14, 2025
Ubiquilin-2 liquid droplets catalyze α-synuclein fibril formationTomoki Takei, Yukiko Sasazawa, Daisuke Noshiro, et al.
BMJ Open|February 12, 2022
Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson's disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD)Taku Hatano, Genko Oyama, Yasushi Shimo, et al.
Nature Medicine|May 29, 2023
Propagative α-synuclein seeds as serum biomarkers for synucleinopathiesAyami Okuzumi, Taku Hatano, Gen Matsumoto, et al.
BMJ Open|October 21, 2025
Randomised, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of antibiotic faecal microbiota transplantation in patients with Parkinson's disease (FLORA-PD): a study protocolHaruka Takeshige-Amano, Eriko Igami, Ayami Okuzumi, et al.
Scientific Reports|March 15, 2023
Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson's disease in JapanGenko Oyama, Maximilien Burq, Taku Hatano, et al.
Pageof 10